The National Health and Care Commission issued a letter to these drug market restrictions.

On July 23, the General Office of the National Health and Care Commission issued the Notice on The Continuing Management of Clinical Application sandhydles of Antimicrobial Drugs (hereinafter referred to as the Notice), which is the second document issued by the National Health and Care Commission this year focusing on antimicrobial drugs.
the "Notice" of optimizing the supply of antimicrobial drugs, medical institutions should optimize the antimicrobial supply catalogue in the context of the "1 plus X" drug use model dominated by essential drugs ("1" is the national list of essential drugs, "X" is non-essential drugs).
in the formulation of the agency's antimicrobial drug supply catalogue and prescription set, in addition to the prescribed specifications to ensure the selection of similar drugs should be selected safe, effective, economic and evidence-based evidence-based varieties. in addition,
, in strengthening the management of key links, we should continue to promote the management of key antimicrobial drugs, focusing on preventive use, joint use and intravenous infusion, intrauterine injection, joint injection of antimicrobial drugs.
to encourage qualified medical institutions to carry out monitoring of the concentration of therapeutic drugs for key antimicrobial drugs and guide clinical precision drug use.
that is, in the future, every hospital will have to select the hospital's antimicrobial supply catalog, into this catalog is very important for antimicrobials, especially injection-type antimicrobials.
strictly speaking, after the anti-bacterial drugs to enter the hospital, in addition to the bidding and procurement process to win the bid, into the hospital drug catalog, but also must go into the hospital's antimicrobial supply catalog.
however, it is worth concerning that under the restriction order, Chinese medicine with antibacterial effect actually has certain advantages.
in the "Clinical Application of Antibacterial Drugs Management Measures" article 2 clearly stated that "the "antimicrobial drugs referred to in these Measures refers to the treatment of bacteria, mycoplasma, chlamydia, likes, spirals, fungi and other pathogenic microorganisms-induced infectious diseases of the drug, excluding treatment of tuberculosis, parasitic diseases and various virus-induced infectious diseases and anti-bacterial agents of Traditional Chinese medicine."
under the influence of the restriction order, there are many anti-bacterial Chinese medicine preparations, such as monkey earrings, pediblue, plate blue root, the market has shown a significant growth trend.
in addition, Chinese medicine tablets, because they do not account for the proportion of medicine, also have a great advantage.
especially in the process of fighting the new crown epidemic, we can also see the advantages of Chinese medicine in the treatment of diseases, under the restriction order, with antibacterial effect of Chinese medicine will usher in greater opportunities for development.
comprehensively promote the management of antimicrobial drugs "Notice" stressed that hospitals above the second level should strictly implement the "Clinical Application Management Measures for Antibacterial Drugs" requirements, and regularly to doctors and pharmacists for the clinical application of antimicrobial drugs knowledge and standardized management training.
physicians may not grant the right to prescribe antimicrobial drugs without training and passing the examination of this institution.
hospitals may not grant the appropriate prescription authority solely on the basis of the title of physician.
the administrative departments of health and health should further standardize the granting and management of the prescription rights of antimicrobial drugs in conjunction with the assessment of rational drug use in medical institutions, and supervise the implementation of the work.
in fact, as early as July 23 this year, the Office of the National Health and Health Commission issued the "Notice on the issuance of the 2020 National Random Inspection Program".
, medical institutions to monitor spot checks programs, including the management of antimicrobial drugs.
antimicrobials, which we often call antibiotics.
a set of data released by the National Development and Reform Commission in 2015 showed that China's medical infusion of 10.4 billion bottles, equivalent to 8 bottles per person, far higher than the international average of 2.5-3.3 bottles.
and in China's outpatient infusion prescriptions, more than 80% of the antibiotics involved, antibiotic abuse caused by human bacterial resistance, the probability of adverse drug reactions increased and other adverse consequences are becoming increasingly serious.
in recent years, China has carried out a number of special rectification of the antibiotic prescription drug market, at present, China in the anti-bacterial drug use management, medical restructuring and hospital and retail drugstore self-discipline have reached a new level, objectively also led to the use of anti-bacterial drugs in hospitals to purchase the amount and amount of sustained and slow growth trend.
on May 10, 2018, the National Health and Care Commission's Medical and Medical Hospital Issued a Notice on continuing to do a good job in the management of clinical application sandhydles of antimicrobial drugs, calling for further strengthening the management of clinical applications of antimicrobial drugs.
This is the first escalation of the resistance order after march 2017, when the National Health and Planning Commission issued a Notice on Further Strengthening the Management of Clinical Applications of Antibacterial Drugs to Curb Bacterial Resistance.
now, in this year, the National Health and Care Commission has issued two notices, clearly continue to strengthen the management of clinical application of antimicrobial drugs, this is again stressed to limit the ban on resistance, with a variety of supporting policies and regulatory measures, the market challenges of antimicrobial drugs are also increasing.
.